TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹14,798 Cr | ₹3,026 Cr | ₹3,937 Cr | ₹5,297 Cr | ₹4,018 Cr |
What is the latest Total Debt ratio of TORRENT PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹14,798 Cr |
| Mar2025 | ₹3,026 Cr |
| Mar2024 | ₹3,937 Cr |
| Mar2023 | ₹5,297 Cr |
| Mar2022 | ₹4,018 Cr |
How is Total Debt of TORRENT PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹14,798 Cr | 389.02 | |
| Mar2025 | ₹3,026 Cr | -23.15 | |
| Mar2024 | ₹3,937 Cr | -25.67 | |
| Mar2023 | ₹5,297 Cr | 31.84 | |
| Mar2022 | ₹4,018 Cr | - | |
Compare Total Debt of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹188,374.1 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| MANKIND PHARMA | ₹100,730.0 Cr | -1.4% | -3.7% | -5.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.3% |
1.1% |
32.7% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses